The average one-year price target for Cytosorbents (NASDAQCM:CTSO) has been revised to $48.45 / share. This is an increase of 1,900.00% from the prior estimate of $2.42 dated August 25, 2026. These figures represent aggregate analyst targets collected by Fintel and do not consti